CDC surveillance estimates autism spectrum disorder prevalence among 8-year-olds in 11 U.S. sites

The Centers for Disease Control and Prevention (CDC) published a surveillance summary estimating autism spectrum disorder (ASD) prevalence among children aged 8 years across 11 sites in the United States. The summary reports CDC estimates of ASD prevalence but provides no specific prevalence numbers, absolute case counts, or statistical measures such as confidence intervals or p-values. No intervention, exposure, comparator, or follow-up period was reported.

This surveillance summary represents descriptive population monitoring rather than clinical research. No safety or tolerability data were reported, as this was not an interventional study. The summary did not report funding sources or potential conflicts of interest.

Key limitations include the absence of specific prevalence numbers, statistical measures, and methodological details about case ascertainment. The practice relevance of this surveillance summary is limited to providing general awareness of ongoing CDC monitoring efforts. Clinicians should await more detailed publications with specific prevalence estimates and methodological details before drawing conclusions about ASD prevalence trends.